LISANDO


Lysando focuses on healing and not just treatment, prioritizing people over profits. They develop microbiome-friendly solutions to combat resistant bacteria and hospital germs, emphasizing the importance of microbiome health and innovative, targeted approaches like Artilysin®s to address bacterial infections and antibiotic resistance. Their mission is to create disruptive, microbiome-respecting therapies that redefine infection treatment and support overall health.

Industries

manufacturing
medical-device

Nr. of Employees

small (1-50)

LISANDO

Regensburg, Bayern, Germany, Europe


Products

Precision-engineered antimicrobial proteins for microbiome-targeted therapy

Protein-based therapeutic candidates engineered to selectively remove pathogenic bacteria, disrupt harmful biofilms and act on metabolically inactive/persister bacteria while preserving beneficial microbes.


Services

Collaborative development and licensing

Partnering with biotech and pharmaceutical organizations to co-develop protein-based antimicrobial candidates and to establish development agreements or licenses.

Clinical and hospital supply donation / emergency provision

Provision of therapeutic material donations or emergency supplies to hospitals and clinical partners (documented donation activity in media materials).

Expertise Areas

  • Microbiome therapeutics
  • Protein engineering and design
  • AI-based drug design
  • Antimicrobial resistance solutions
  • Show More (3)

Key Technologies

  • AI-driven protein design
  • Protein engineering
  • Construct/module sequence libraries
  • In vitro biofilm and persister assays
  • Show More (2)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.